Home › Bone Cancer › NCT07215611

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

Who can join

All ages · All sexes

Inclusion Criteria:

* Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified.
* Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor.

Exclusion Criteria

• Non-English subjects will not be recruited. Subjects are required to be able to read/write in English.

About the study

To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.

What is being tested

• data collection (other)

Sponsor: M.D. Anderson Cancer Center · Participants: 100 · Started: Sep 2, 2025

Contact the study team

• Shalin S Patel, MD · Phone: 713-792-6268

Official record on ClinicalTrials.gov — NCT07215611

Locations in the U.S.

Conditions

• Bone Cancer
• Financial Stress

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.